The Recent Advances on Liver Cancer Stem Cells: Biomarkers, Separation, and Therapy

51Citations
Citations of this article
48Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

As the third major reason of mortality related to cancer in the world, liver cancer is also the fifth most frequent cancer. Unluckily, a majority of patients succumb and relapse though many progresses have been made in detection and therapy of liver cancer. It has been put forward that in liver cancer, cancer stem cells (CSCs) hold main responsibility for the formation, invasion, metastasis, and recurrence of tumor. Strategies that are intended to target liver CSCs are playing a more and more significant role in supervising the development of liver cancer treatment and assessing new therapeutic methods. Herein, a brief review about molecule markers, signal pathways, separation, and treatment on liver cancer stem cells (LCSCs) is provided in this paper.

Cite

CITATION STYLE

APA

Xiao, Y., Lin, M., Jiang, X., Ye, J., Guo, T., Shi, Y., & Bian, X. (2017). The Recent Advances on Liver Cancer Stem Cells: Biomarkers, Separation, and Therapy. Analytical Cellular Pathology. Hindawi Limited. https://doi.org/10.1155/2017/5108653

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free